IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 155 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $241,000 | -68.7% | 7,335 | -73.9% | 0.00% | -75.0% |
| Q2 2020 | $771,000 | +15.8% | 28,101 | +26.3% | 0.00% | 0.0% |
| Q1 2020 | $666,000 | -3.5% | 22,246 | -10.8% | 0.00% | +33.3% |
| Q4 2019 | $690,000 | +52.0% | 24,941 | 0.0% | 0.00% | +50.0% |
| Q3 2019 | $454,000 | -61.7% | 24,941 | -48.4% | 0.00% | -66.7% |
| Q2 2019 | $1,185,000 | +100.8% | 48,330 | -22.1% | 0.01% | +100.0% |
| Q1 2019 | $590,000 | – | 62,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,944,201 | $27,999,000 | 13.31% |
| Broadfin Capital, LLC | 4,328,303 | $41,162,000 | 8.50% |
| GREAT POINT PARTNERS LLC | 5,567,348 | $52,945,000 | 5.24% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $20,811,000 | 5.01% |
| Avoro Capital Advisors LLC | 10,530,862 | $100,148,000 | 4.33% |
| Prosight Management, LP | 917,080 | $8,721,000 | 3.82% |
| Perceptive Advisors | 12,235,811 | $116,362,000 | 3.28% |
| Ghost Tree Capital, LLC | 1,150,000 | $10,937,000 | 2.86% |
| QVT Financial LP | 1,021,361 | $9,241,000 | 2.32% |
| Cheyne Capital Management (UK) LLP | 186,500 | $1,774,000 | 1.66% |